LYSIS SOLUTION - ANVISA Registration 10303460431

Access comprehensive regulatory information for LYSIS SOLUTION in Brazil's medical device market through Pure Global AI's free database. This Risk Class I medical device is registered under ANVISA number 10303460431 and manufactured by IN VITRO DIAGNOSTICA LTDA. The registration is held by IN VITRO DIAGNOSTICA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including DIAGNO SOLUÇÕES EM DIAGNÓSTICO LTDA, SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10303460431
Registration Details
ANVISA Registration Number: 10303460431
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

HCB - LIS CF
Risk Class I

Registration Details

10303460431

25351723509201115

42837716000198

Company Information

Brazil
PT: BRASIL

Dates and Status

Feb 06, 2012

VIGENTE

09/18/2025 19:00:01